Preparing for COVID-19-related Drug Shortages

Ann Am Thorac Soc. 2020 Aug;17(8):928-931. doi: 10.1513/AnnalsATS.202004-362VP.

Authors

Andrew G Shuman^{1

2}, Erin Fox³, Yoram Unguru^{4

5}

Affiliations

¹ Center for Bioethics and Social Sciences in Medicine, and.
² Michigan Institute for Clinical and Health Research, University of Michigan Medical School, Ann Arbor, Michigan.
³ Department of Pharmacy, University of Utah Health, Salt Lake City, Utah.
⁴ Division of Pediatric Hematology/Oncology, The Herman and Walter Samuelson Children's Hospital at Sinai, Baltimore, Maryland; and.
⁵ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland.

No abstract available

MeSH terms

Betacoronavirus
COVID-19
Civil Defense / organization & administration
Civil Defense / standards
Coronavirus Infections* / drug therapy
Coronavirus Infections* / epidemiology
Coronavirus Infections* / prevention & control
Delivery of Health Care, Integrated / methods
Delivery of Health Care, Integrated / trends
Drugs, Essential / supply & distribution*
Health Services Needs and Demand
Humans
Medication Therapy Management / organization & administration*
Pandemics* / prevention & control
Pneumonia, Viral* / drug therapy
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / prevention & control
SARS-CoV-2
Strategic Stockpile / methods
Strategic Stockpile / organization & administration
United States / epidemiology

Substances

Drugs, Essential